Date: Aug 28, 2003 Source: NIH Success Stories (
click here to go to the source)
Technology Developed:
Plate based assays for non-radioactive determination of PI(3,4,5)P3 levels and PI 3-K activity in vitro and in biological samples.
Key Words: Phosphoinositide 3-Kinase, PI 3-K, PI(3,4,5)P3, PI 3-Kinase, PI3K, Echelon.
Uses of Technology/Products/Service:
Echelon has developed a non-radioactive way to measure and detect Phosphoinositide 3-Kinase activity in vitro and in biological samples. This technology has applications in cancer research focused on the PI 3-K cell signaling pathway. This pathway is suspected to play a major role in certain types of cancer.
Benefit to Company:
The benefit to our company from the PI 3-Kinase assay kit is: 1. Development of PI 3-K assay has lead to other ground-breaking research which has lead to more grants and more products. 2. New products have lead to increased sales revenue.
How Product Was Commercialized:
The PI 3-Kinase assay kit was commercialized through direct mail, tradeshow promotion, an email campaign, new product releases in content relevant publications and through research publication in peer reviewed journals.
